Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 8.01, 9.01 · 8-K

SiriusPoint Ltd.

SPNTNYSEEQUITYCurrent

Other Events

Item 8.01. Other Events. On September 29, 2025, a subsidiary of SiriusPoint Ltd. (the “Company”) entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company of the Company’s wholly owned supplemental health insurance program manager, ArmadaCare (“Armada”), to a subsidiary of Ambac Financial Group Inc. for a purchase price of $250 million.…

Filed Sep 29, 2025Accepted Sep 29, 2025, 5:02 PM EDTCIK 1576018Accession 0001193125-25-223398
Share

Company context

SiriusPoint is a global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. Bermuda-headquartered with offices in New York, London, Stockholm and other locations, we are listed on the New York Stock Exchange (SPNT). We have licenses to write Property & Casualty and Accident & Health insurance and reinsurance globally. Our offering and distribution capabilities are strengthened by a portfolio of strategic partnerships with Managing General Agents and Program Administrators within our Insurance & Services segment. With approximately $2.8 billion in total capital, SiriusPoint’s operating companies have a financial strength rating of A- (Excellent) from AM Best, S&P and Fitch, and A3 from Moody’s. For more information, please visit www.siriuspt.com.

Current securities

Historical securities (3)

Recent company filings

  1. SCHEDULE 13G - filed by WELLINGTON MANAGEMENT GROUP LLP regarding SiriusPoint LtdNov 16, 2026
  2. SCHEDULE 13G - filed by DONALD SMITH & CO., INC. regarding SiriusPoint LtdNov 13, 2026
  3. 10-Q filingNov 5, 2026
  4. Results of Operations and Financial Condition · Regulation FD Disclosure · Other EventsNov 5, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsNov 3, 2026

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events. On September 29, 2025, a subsidiary of SiriusPoint Ltd. (the “Company”) entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company of the Company’s wholly owned supplemental health insurance program manager, ArmadaCare (“Armada”), to a subsidiary of Ambac Financial Group Inc. for a purchase price of $250 million. The closing of the transaction is subject to customary closing conditions, including receipt of regulatory approvals. On September 29, 2025, the Company issued a press release announcing the entry into the definitive agreement for the sale of the Armada business. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Filed exhibits (1)
EX-99.1 (by filename) d14461dex991.htm

EX-99.1 2 d14461dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 PRESS RELEASE SiriusPoint Announces Sale of ArmadaCare MGA for $250m with Long Term Capacity Deal Until 2030 Hamilton, Bermuda (September 29, 2025) - SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced its agreement to sell wholly owned supplemental health insurance program manager, ArmadaCare (“Armada”) to Ambac Financial Group Inc. (“Ambac”) for $250 million. SiriusPoint will continue its capacity partnership with Armada until the end of 2030. Upon completion of the sale, SiriusPoint will recognize a pre-tax gain of $220-230 million, with the transaction valuing Armada at approximately 14x EBITDA1. Pro-forma tangible book value is expected to increase by approximately 10% upon close. Scott Egan, SiriusPoint’s Chief Executive Officer, said: “The sale of our equity stake is an important step in unlocking the significant off-balance sheet value of Armada. We look forward to continuing our strong partnership with the team through our long-term capacity agreement. “We are proud of our leading capabilities in the Accident & Health segment, which includes our owner…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.